Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Teva Pharmaceutical, a manufacturer of generics and branded drugs, has introduced Naratriptan film-coated tablets.
Subscribe to our email newsletter
Naratriptan is a generic equivalent form of GlaxoSmithKline’s Naramig (Naratriptan Hydrochloride), indicated in the acute treatment of the headache phase of migraine attacks with or without aura.
Teva commercial director Kim said the company wants to make more medicines accessible for more people and Naratriptan is its fifth day-one launch this year to add to its portfolio of over 700 products.
"Importantly, it also means we continue to help save the NHS over £9bn on generic prescriptions," Innes added.